Company intelligence / Profile preview

CDH Genetech

Cayman Islands

Ownership: Private
Development stage: Other

Overview

CDH Genetech is an investment holding entity, wholly owned by CDH Fund V, L.P., used as a vehicle by CDH Investments to invest in healthcare/biotechnology assets such as Sirtex Medical. It does not itself develop drugs or run clinical programs.[4][6][8]

Industry: Investors

Partnerships

China Grand Pharmaceutical and Healthcare Holdings (joint acquisition and ownership of Sirtex Medical)[4][5][6][8]

Beyond the preview

Go deeper on CDH Genetech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDH Genetech.

Explore the full profile